Inter-clinician agreement on the recognition of clinical pigmentary characteristics of patients with cutaneous malignant melanoma. Studies of melanocytic nevi, VI. by Roush, G. C. et al.
Br. J. Cancer (1991), 64, 373-376
Inter-clinician agreement on the recognition of clinical pigmentary
characteristics of patients with cutaneous malignant melanoma.
Studies of melanocytic nevi, VI
G.C. Roush, R.L. Barnhill, M.S. Ernstoff & J.M. Kirkwood
Dermatopathology Division andDermatology Service, Massachusetts General Hospital and Harvard Medical School, Boston,
Massachusetts 02114; Cancer Prevention Research Institute, 36 East 22nd Street, New York 10010; Division ofMedical Oncology,
Department ofMedicine, University ofPittsburgh School ofMedicine, Pittsburgh, Pennsylvannia 15213, USA.
Summary The number and type of melanocytic nevi are among the most important known predictors of risk
for cutaneous malignant melanoma. In this study, examinations of the skin were conducted by two to four
clinicians on 153 patients with newly diagnosed melanoma, and the agreement among clinicians was quantified
regarding number of nevi and freckling. The index of agreement (calculated as the intra-class correlation
coefficient) was 59.7% and 69.0% for freckling on the right forearm and on the shoulders, respectively;
agreement was above 50% for only one of six pairs of clinicians in examining freckling on the right forearm,
while agreement was above 50% for four of the six pairs of clinicians in examination of freckling on the
shoulder. For palpable nevi of the arms (used in at least two case-control studies as a predictor of risk), the
agreement was 36.1% when computed for three examiners assessing 81 patients. However, for total arm nevi
(both palpable and non-palpable), assessed on a subset of 48 patients, the agreement was 88.2%; this and
other analyses indicated that the difficulty in achieving a consensus for palpable nevi lay in whether or not
lesions were considered to be 'palpable' or 'non-palpable'. Agreement for total number of atypical nevi on the
body and total number of all types of nevi were 87.4% and 91.8% respectively.
These data suggest that the kinds of lesions on which agreement might be reached are total atypical nevi
and total nevi of all types on the arms and on the entire body. Greater difficulty might be found in achieving
consistency among investigators and among clinicians in examining individual patients with respect to
freckling on the arms and 'palpable' nevi. However, some consistency was achieved even with these latter two
clinical features.
Several case-control studies in recent years have documented
elevated risk for malignant melanoma in individuals with
freckling tendency, for persons with increased numbers of
acquired melanocytic nevi (Dubin et al., 1986; Elwood et al.,
1986; Green et al., 1985a; Holman & Armstrong, 1984b;
Beral et al., 1983; Hicks et al., 1985; Swerdlow et al., 1986)
and for persons with clinically atypical nevi (Swerdlow et al.,
1986; MacKie et al., 1989). If such information is to be
utilised in epidemiologic and clinical research and in the
management of patients potentially at risk for melanoma, it
is important that the clinical characteristics of pigmented
lesions are reliably recognised and readily communicated
among physicians and researchers. However, on review of the
medical literature, we have found little quantitative data on
this important question. In the present study, we have quan-
tified for the first time rates of inter-clinician agreement in
assessment of freckling and enumeration of melanocytic nevi
in 153 consecutively-examined patients with cutaneous mela-
noma.
Materials and methods
One hundred and fifty-three newly-diagnosed melanoma
patients participated in the study and were examined in the
Yale Melanoma Unit from 1 January 1983 to 1 July 1987.
Participants were selected from incident cases of malignant
melanoma referred to the Yale Melanoma Clinic for evalua-
tion and treatment primarily from the southern Connecticut
region. Criteria for enrollment in the study included newly-
diagnosed malignant melanoma, non-Hispanic caucasian sub-
jects, age limitation: above 20 and under 70 years of age.
Patients with these criteria were invited to enroll in the study
and informed consent was obtained. The proportion of eligi-
ble patients who actually participated exceeded two-thirds.
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All study subjects underwent an exam of the entire skin,
excluding the genitalia and including an assessment of freckl-
ing characteristics; a count of palpable arm nevi below the
level of the axillae (nevi could be of any size); a count of any
nevi on the arms, palpable or not; a count of total body nevi
3 mm or greater in longest diameter, a count of the total
number of atypical nevi, and an in-depth assessment of the
atypical nevi (Barnhill et al., 1990). Freckles were defined as
light-tan to brown, completely macular lesions, without any
surface change or distortion of skin cleavage lines, and gener-
ally measuring from 2-3 mm to 10 mm in diameter. Melano-
cytic nevi were defined as relatively flat (but associated with
accentuation of skin cleavage lines) or raised lesions,
generally measuring greater than 3 to 5 mm in diameter, and
pink, flesh-coloured, or pigmented. Distinction of a junc-
tional nevus from a simple lentigo is difficult. In our exper-
ience, most lentigines are macular, do not exhibit distortion
of skin cleavage lines, and measure 2-3 mm in diameter (but
may be larger). Junctional nevi, on the other hand, are
frequently slightly palpable, exhibit distortion of skin
cleavage lines, and usually measure greater than 3 mm in
size. A small proportion of lesions can only be distinguished
by histological examination. Nevi were further defined as not
being obvious seborrheic keratoses, solar lentigines, warts or
dermatofibromas. The designation of a nevus as atypical was
based on the subjective assessment of each individual exam-
iner, but generally was related to the presence of three or
more of the following gross morphological features: size
greater than 5 mm, asymmetry, irregular border, ill-defined
border, macular component, haphazard colour. If any nevi
were present, the clinical characteristics of up to eight of the
most atypical nevi were recorded.
Clinical features evaluated
The following clinical characteritics were correlated with
histomorphological features:
1. Estimation offreckling on shoulders: scored as less than
20 freckles, 20 to 50 freckles, and greater than 50
freckles.
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2. Estimation of freckling on right forarm: scored as
above.
3. Number of palpable arm nevi below level of axillae of
any size.
4. Number of nevi on arms below level of axillae, palpable
or not, of any size.
5. Total number of nevi on body 3 mm or greater in
longest diameter.
6. Total number of atypical nevi on body.
With respect to assessment of freckling, prior to initiation
of the study, the authors gave a great deal of consideration
to approaches in enumerating freckling. The authors found it
difficult to agree on an approach other than the one present-
ed here with three categories. The authors did attempt to
literally 'count freckles' but found it impossible in view ofthe
simple fact that freckles are often contiguous. Also, recent
sun exposure, clothing and age may lead to more or less
contrast in skin markings, and these would vary day-by-day
for any given patient. Therefore, the authors felt that a scale
involving three categories was perhaps the most detailed
approach that was acceptable.
Each patient was independently examined by two to four
physicians: two medical oncologists (Examiners I and II), an
internist-epidemiologist (Examiner III), and a dermatologist-
dermatopathologist (Examiner IV). Initially, there were great
differences in prior experience in the clinical evaluation of
melanocytic nevi and cutaneous melanoma: Examiners II and
IV had greater than 5 years experience, Examiner I had
approximately 2 years, and Examiner III had several weeks.
The number of patients assessed by each examiner varied
from 76 (Examiner II) to 153 (Examiner III) with the major-
ity of patients evaluated by Examiners I, III, and IV. Varia-
tion in the number of nevi analysed in the study was also
dependent on the presence of a complete set of observations
for each lesion.
The two oncologists (Examiners I and II) had similar
dermatologic training in that examiner I learned primarily
from Examiner II. Examiner III, the epidemiologist, learned
from the two oncologists and as well as from a Professor in
the Department of Dermatology at Yale. Examiner IV, the
dermatologist, was trained elsewhere. Examiners I, II and III
did compare themselves on selected features prior to the
study, and, during the study, all four examiners did occa-
sionally compare their observations (but only after recording
observations on a particular study patient).
The examiners considered how intra-clinician variation
could be evaluated. However, in view of the dynamic nature
of pigmented lesions, re-examiation of the same individual
did not seem meaningful to us. 'Re-examination' could have
been accomplished over many months, but a great number of
photographs would have been required to avoid responses
being recorded simply on the basis of recalling the prior
decision about that photography. Although re-examinations
have been accomplished on some patients over months to
years (particularly for Examiners III and IV), the authors do
not have plans to report this information. Intra-clinician
variation may be less important than other types of quality
control.
Analysis of agreement was based on cross-classification of
pairs of examiners and in calculation of the intraclass cor-
relation coefficient, expressed as percent (Holman & Arm-
strong, 1984b). Poor agreement occurs when this index
approaches 0% (or is negative) and agreement is perfect
when the index is 100%.
The limitation of the intraclass correlation is that it strictly
requires the assumption of normal distribution. However, the
results are generally not affected dramatically by this prob-
lem.
Results
Table I summarises the mean score for each variable and for
each of the four examiners. Examiner II seemed to have
Table I Mean score for each examiner
Examiner
Pigmentary characteristics I II III IV
Freckling, right forearm (n = 62)1 1.6 1.4b 1.9 2.0c
Freckling, shoulder (n= 62)1 2.1 1j9b 2.5 2.5c
Any ann nevi (n = 49) 7.4 3.2d 5.0 6.7
Palpable arm nevi (n= 34) 3.4 2.3 2.9 3.4
Total atypical nevi (n = 31) 3.5 3.2 2.2 1.5
Total body nevi (n = 32) 16.4 19.2 14.9 15.5
aEstimates offreckling were scored as: 1 = <20 freckles, 2 = 20-50
freckles, 3 = >50 freckles. In order to appropriately compare mean
values, the means are computed only for that fraction of the 153
participants examined by multiple examiners on the same visit, and
therefore n varied from 31-62. 'This number was based on 13 patients
notincludedin thesampleof62patients.'Thisnumberwasbased on 55
patients, all ofwhom were included in the sample of62 patients. dThis
number was based on 37 patients, some ofwhom were examined in the
sample of49 patients.
recorded less freckling, and fewer arm nevi and palpable arm
nevi. However, his counts of total atypical nevi and total
numbers of any type of nevi were comparable to those of
others.
Table II provides the cross classification of Examiner III
with Examiner IV for each of the pigmentary features. These
examiners were chosen because of the large number of simul-
taneoulsy examined patients. Table II indicates the inherent
method for examining agreement. Crude agreement is based
on the number of persons examined for which the two
examiners agree exactly, which implies that the categories lie
on the diagonal. For example, for the number of freckles on
the right forearm, the crude agreement is (19 + 8 + 18)/67,
which equals 67.2%. In order to simplify presentation of the
data, we have formed categories for all of the variables
containing numbers of nevi. For number of freckles on the
shoulders, the crude agreement for the two examiners is
66.2%, for number of palpable arm nevi it is 53.3%, for any
arm nevi it is 50.0%, for total number of atypical nevi it is
66.7% and for total number of any type of nevi it is 61.0%.
Clearly, the greater the number of categories, the less the
likelihood that exact agreement will be achieved. Further, the
results for crude agreement reflect a dichotomy (agreement
either exists or it does not exist), and therefore is not a very
refined measure.
Table III provides the intra-class correlation coefficient,
which partly serves the purpose of addressing both of the
two problems noted above (i.e. dichotomous classification of
agreement and arbitrary number ofcategories affecting agree-
ment). Table III shows the computations for each pair of
examiners. For Examiner III vs Examiner IV, the agreement
can be found in the lower right hand corner of each subtable
of Table III as 66.4% for forearm freckling, 66.1% for
shoulder freckling, 25.4% for palpable arm nevi, 87.1% for
total number of atypical nevi, and 78.0% for total numbers
of nevi of any type. Considering each of the six possible pairs
of examiners, there is reasonably good agreement, with the
exception of Examiner II vs Examiner III in forearm freck-
ling and Examiner II vs Examiner IV in forearm freckling,
shoulder freckling and palpable arm nevi. However, for total
body nevi and for total atypical nevi, the agreement between
the two of each of the six pairs was 61% or better.
Table IV indicates results when computing agreement
among three or more examiners simultaneously, again with
the intra-class correlation coefficient. Most of the combina-
tions involved Examiners I, III and IV. These summary
measures showed the poorest agreement for palpable arm
nevi and the best agreement (87% to 92%) for total arm
nevi, total body nevi, and total atypical nevi.
Discussion
These results demonstrate agreement of 87% or greater for
nevi on the arms, total nevi on the body and for totalINTEROB3.MAN 375
Table II Agreement ofExaminer IIIwith Examiner IVforeach ofthe
pigmentary features
Numbers offreckles on the rightforearm
Examiner IV
Examiner III <20 20-49 S0 + Total
<20 19 5 2 26
28.36% 7.46 2.99 38.81
20-49 2 8 3 13
2.99 11.94 4.48 19.40
50 + 2 8 18 28
2.99 11.94 26.87 41.79
Total 23 21 23 67
34.33 31.34 34.33 100.00
Crude agreement 67.2%
Numbers offreckles on the shoulders
Examiner IV
Examiner III <20 20-49 50 + Total
<20 6 7 0 13
8.82% 10.29 0.00 19.12
20-49 1 5 5 11
1.47 7.35 7.35 16.18
50 + 1 9 34 44
1.47 13.24 50.00 64.71
Total 8 21 39 68
11.76 30.88 57.35 100.00
Crude agreement 66.2%
Number ofpalpable arm nevi
Examiner IV
Examiner III None 1-2 3-5 6 + Total
None 11 9 1 1 22
10.48% 8.57 0.95 0.95 20.95
1-2 10 14 7 2 33
9.52 13.33 6.67 1.90 31.43
3-5 2 6 11 8 27
1.90 5.71 10.48 7.62 25.71
6+ 0 1 2 20 23
0.00 0.95 1.90 19.05 21.90
Total 23 30 21 31 105
21.90 28.57 20.00 29.52 100.00
Crude agreement 53.3%
Number ofnevi ofany type on the arms
Examiner IV
Examiner III 0 1-3 4-8 9 + Total
0 5 5 0 0 10
8.33% 8.33 0.00 0.00 16.67
1-3 6 11 4 4 25
10.00 18.33 6.67 6.67 41.67
4-8 0 4 5 6 15
0.00 6.67 8.33 10.00 25.00
9+ 0 0 1 9 10
0.00 0.00 1.67 15.00 16.67
Total 11 20 10 19 60
18.33 33.33 16.67 31.67 100.00
Crude agreement 50.0%
Number ofany atypical nevi on the entire body
Examiner IV
Examiner III 0 1-2 3 + Total
0 34 8 0 42
35.42% 8.33 0.00 43.75
1-2 10 15 1 26
10.42 15.63 1.04 27.08
3+ 6 7 15 28
6.25 7.29 15.63 29.17
Total 50 30 16 96
52.08 31.25 16.67 100.00
Crude agreement 66.7%
Number oftotal nevi on the body
Examiner IV
Examiner III 0-5 6-10 11-24 25 + Total
0-5 23 1 1 0 25
21.90% 0.95 0.95 0.00 23.81
6-10 7 12 7 0 26
6.67 11.43 6.67 0.00 24.76
11-24 3 11 9 5 28
2.86 10.48 8.57 4.76 26.67
25+ 0 1 5 20 26
0.00 0.95 4.76 19.05 24.76
Total 33 25 22 25 195
31.43 23.81 20.95 23.81 100.00
Crude agreement 61.0%
Table III Inter-clinician agreement forpaired examiners as measured
by intraclass correlation coefficient (expressed as percent)
Clinicalfeatures Examiner II III IV
Freckling, right forearm I 20.0 38.3* 48.6*
II - -8.6 6.2
III - - 66.4*
II III IV
Freckling, shoulder I 68.8** 55.1* 46.5*
II - 56.7** 7.9
III - - 66.1*
II III IV
Palpable arm nevi I 69.1* 85.5* 63.2*
II - 82.2* 5.1
III - - 25.4**
I III IV
Total arm nevi I NA 80.3* 84.4*
II - NA NA
III - - 77.8*
II III IV
Total body nevi I 79.7* 88.8* 85.7*
II - 86.4* 92.1*
III - - 87.1*
II III IV
Total atypical nevi I 87.5* 71.1* 72.1*
II - 73.4* 60.5*
III - 78.0*
*P<0.001; **P<0.013; NA = not available.
Table IV Inter-clinician agreement among three examiners on clinical
features with intraclass correlation coefficient (expressed as percent)
Number of Correlation
Clinicalfeatures patients coefficient
Freckling, right forearm 52 59.7*
Freckling, shoulders 52 69.0*
Palpable arm nevi 81 36.1*
Total arm nevi 48 88.2*
Total body nevi 79 91.8*
Total atypical nevi 73 87.4*
*P<0.001.
numbers of atypical nevi. Although there is some consistency
in evaluating palpable arm nevi and freckling, the results
suggest greater difficulty with these latter clinical features.
A number ofepidemiologic studies have demonstrated that
malignant melanoma is associated with each of these types of
variables. Relative risks for melanoma in those with freckling
have generally been elevated in the range of 2 to 4-fold
(Elwood et al., 1986; Klepp & Magnus, 1979; Beral et al.,
1983; Roush et al., 1985, 1987). However, both total numbers
of nevi of any type and total numbers of atypical nevi are
associated with relative risks from 3 to 30-fold, with most
results being in the area of 5 to 20-fold (Elwood et al., 1986;
Holman & Armstrong, 1984b; Roush et al., 1985; Roush et
al., 1987; Roush et al., 1988; Roush et al., 1988; Nordlund et
al., 1985; Green et al., 1986; Holly et al., 1986; Rhodes et al.,
1980). Thus, the epidemiologic studies would suggest that
nevi (either total nevi or numbers of atypical nevi) are better
predictors of melanoma than freckling. If this is true, one
possible explanation might be biologic (e.g., that nevi might
be direct precursors of melanoma) (Roush, 1988; Roush et
al., 1988). However, the present results suggest another ex-
planation, namely, that inconsistencies in categorisation of
freckling may obscure an otherwise high relative risk for
melanoma due to freckling.
While two previous studies have touched on the subject of
inter-observer agreement on clinical diagnosis of nevi
(MacKie et al., 1985; Cooke, 1988) there are no concordance
studies providing quantitative data on numbers of nevi. In a
study of 432 healthy volunteers, MacKie and colleagues
recorded the total number of nevi 3 mm or greater in dia-
meter for each individual. Excellent inter-observer agreement
between two dermatologists was reported (MacKie et al.,
1985) for nevus counts carried out in 20 subjects, but no
quantitative data were provided. Cooke, Elder and Greene
recorded rates of agreement on clinical diagnosis of nevi in a376 G.C. ROUSH et al.
survey of melanocytic nevi in Milton, New Zealand (Cooke,
1988). The three observers reviewed 200 clinical photographs
of flat, tan nevi 2 to 4 mm in diameter and concurred on a
diagnosis of melanocytic nevus in 89% of the lesions. How-
ever, they did not study rates of agreement on total numbers
of nevi.
Our results concerning counting of nevi indicate that all
categories of nevi were reliably recorded by the examiners. In
fact, except for one pair of examiners assessing palpable arm
nevi, there was statistically-significant concordance among all
pairs of observers for all counts of nevi (Table III). Similarly
there was overall agreement among the correlations for the
three examiners in Table IV. The highest correlation coeffi-
cients were recorded for counts of total body nevi (Tables III
and IV). From these results we believe that in general nevi
can be reliably counted.
Potential sources of misdiagnosis on clinical evaluation of
nevi include simple lentigines (confusion with junctional or
occasionally compound nevi), solar lentigines, and seborrheic
keratoses. However, based on histologic evaluation of lesions
removed, we have found that the latter categories of lesions
account for about 6% of all pigmented lesions clinically
diagnosed as melanocytic nevi (Barnill & Roush, 1990).
In conclusion, the present study has provided the first
comprehensive evaluation of inter-clinician agreement on
clinical assessment of freckling and quantification of nevi.
Our findings have shown that numbers of nevi can be con-
sistently recorded by physicians of varied medical back-
ground and experience. These results are also of considerable
relevance to epidemiologic research concerning risk factors
for cutaneous melanoma and also for comparison of results
from different studies on this topic.
The contributions of Drs Paul Duray and Linda Titus-Ernstoff are
greatly appreciated. We also thank Miss Michelle Wood for her
efforts in the preparation of the manuscript.
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